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Postmortem toxicological analysis is often an important tool in autopsy in determining the cause 
of death.  There are circumstances however when traditional samples such as blood and vitreous 
fluid are unobtainable.  In such instances, alternative body fluids such as synovial fluid may be 
useful adjuncts.  However, synovial fluid has not been accepted as a widely used alternative.  
The purpose of this study was to determine the correlation between blood ethanol content and 
synovial fluid ethanol content.  To this end, synovial fluid was obtained from 98 cases presenting 
to the Office of the Medical Investigator in Albuquerque, New Mexico over a 4 month period.  
Of these, 20 cases had measurable blood ethanol content at the time of demise, and were selected 
for use in the present pilot study to determine the viability of using synovial fluid as an 
alternative specimen for postmortem toxicology screening.  Analysis of synovial fluid ethanol 
content (SEC) was performed using gas chromatography and compared with similarly obtained 
blood ethanol content (BEC).  BEC and SEC were found to have a strongly positive linear 
relationship, with a Pearson correlation coefficient of 0.96 and a p-value of <0.0001.  The 
present study confirms prior research which indicates synovial fluid is a suitable substitute for 
the analysis of blood ethanol content particularly when traditional toxicology samples are 
unavailable. 
Abstract 
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Introduction 
Newspaper articles (Zaragoza, 2005), reports by the Center of Disease Control, and the 
New Mexico Department of Health (NM 2005) all indicate that New Mexico has one of the 
highest death rates associated with drugs and ethanol use anywhere in the United States.  The 
Office of the Medical Investigator (OMI) by the decree of state law, maintains jurisdiction over 
sudden, unexpected, and violent deaths in state of New Mexico.  These include deaths that 
involve common drugs of abuse and ethanol intoxication.  Therefore, the OMI is an ideal setting 
in which to examine new and novel approaches to determining the presence and concentration of 
drugs of abuse and ethanol in the deceased.  The purpose of this pilot study is to demonstrate 
with a larger sample population, that analysis of synovial fluid to detect ethanol levels is a viable 
alternative to traditional toxicology screening techniques.  
A vital component of postmortem examinations in cases of sudden, unexpected, and 
violent death is toxicology screening, aimed at detecting numerous substances that may be 
present in the body at the time of death.  There are three major components of toxicology 
screening: separation of the drug from tissue, purification, and analytical detection and 
quantification (DiMaio & DiMaio, 2001).  Forensic toxicology encompasses not only the 
identification and quantification of drugs in the postmortem body, but also offers an 
interpretation as to whether the drug was the primary cause of death, a contributing factor, or had 
no role in the individual’s demise (DiMaio & Dana, 1998).  There has been some concern about 
postmortem metabolism of drugs and diffusion of drugs into body tissues that would potentially 
invalidate definitive reporting of drug levels at the time of death (Saukko & Knight, 2004).  For 
this reason, sampling from various fluids is the standard of forensic toxicology screening.  
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Blood from multiple body sites, vitreous fluid, and urine are the established fluids 
collected at the time of autopsy and subjected to toxicology screening (DiMaio & Dana, 1998).  
However, there are circumstances when these fluids cannot be used due to excessive trauma, 
partial remains, postmortem animal activity, and postmortem changes.  Postmortem changes 
result in the potential for postmortem organism growth to alter the level of ethanol.  Given that 
the synovial fluid is within the protected bursa sac, postmortem changes and redistribution may 
have less effect on ethanol levels in the synovial fluid as compared to other samples.  As such, it 
may be that synovial fluid is one of the most valuable, as yet fully unexplored, samples that can 
be used by forensic toxicology for determining the presence and quantification of ethanol in the 
recently deceased.   
In the past, little consideration has been given to the analysis of synovial fluid as a viable 
alternative despite the fact that there have been a few studies of small sample sizes that have 
indicated its potential relevance.  Ohshima et al. (1997) and Winek et al. (1993) both found a 
high correlation between synovial ethanol content and blood ethanol content (BEC), showing 
that ethanol did equilibrate with synovial fluid, as it does with vitreous (more commonly referred 
to in literature as BAC and SAC for blood alcohol content and synovial fluid alcohol content, 
respectively).  Balabanova (1991, 1993) detected the presence and concentration of nicotine and 
tetrahydrocannabinol in synovial fluid.  More recently, Felscher et al. (1998) screened for the 
presence of a large panel of pharmaceuticals and drugs of abuse, including metabolites, in 
synovial fluid.  Felscher’s research was the most comprehensive to date, but focused on 
establishing the usefulness of fluorescence polarization immunoassays for detection of 
substances, rather than on the power of synovial fluid as a viable toxicology screening sample. 
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Winek et al. (1993), Ohshima et al. (1997), and Felscher et al. (1998) all report that 
synovial fluid demonstrates the necessary properties to be useful in toxicology screening.  
However, all of these studies used divergent methods for collecting and processing specimens, 
different analytical methods for interpreting their data, and different markers for comparison.  
Combined, this leaves open the opportunity to establish a practical and uniform protocol that can 
be directly applied in the autopsy suite and laboratory to collect and analyze synovial fluid for 
ethanol, particularly when traditional samples are unavailable. 
Constituently, synovial fluid shares many of the same qualities of vitreous fluid such as 
being an ultrafiltrate and being constrained to an isolated environment devoid of enzymes that 
can degrade ethanol or other drugs, conditions which generally make vitreous a good candidate 
for toxicology screening.  Synovial fluid is composed primarily of protein constituents derived 
directly from plasma.  The transfer of plasma proteins to synovial fluid is inversely related to the 
size and shape of the molecule and directly correlated with the degree of inflammation (Sokoloff 
Volume I, 1980).  Combined with these plasma proteins are those constituents secreted by the 
joint tissues themselves, including a highly viscous hyaluronic acid mixed with collagen, 
chondroitin sulfate (a glucosaminoglycan), collagenase, and proteinase inhibitors (Sokoloff 
Volume I, 1980).  There is generally a trace quantity of cholesterol present.  Synovial fluid has a 
leukocyte concentration of about two hundred cells per cubic millimeter, a minority of which are 
neutrophils.  No erythrocytes or platelets are present in normal joint fluid (Sokoloff Volume II, 
1980).  A knowledge of the normal components of synovial fluid is important for identifying 
those compounds that are anomalous such as ethanol, drugs of abuse (and their metabolites), or 
pathological conditions (i.e. inflammatory arthritis) that may interfere with the detection of 
ethanol or drugs. 
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 Reiterated, the value of synovial fluid is the fact that the drugs of interest cross into the 
joint space or synovial fluid via the ultrafiltrate yet they exist in the absence of ethanol 
dehydrogenase and other drug-altering metabolic enzymes.  This means any confounding effects 
of drug diffusion within the body’s circulation, or postmortem metabolism of ethanol should be 
limited.   
It is apparent from a review of literature that further research is required to determine the 
strength of the correlation between synovial ethanol content and blood.  The potential for using 
synovial fluid in the analysis of drugs of abuse remains largely untapped.  Thus, it is the purpose 
of this study to determine if synovial fluid can be used as a reliable medium for postmortem 
toxicology screening of ethanol.   
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Materials & Methods 
Sample Collection 
The subjects for this study were recently deceased adolescents or adults, with or without 
a case history indicating possible ethanol involvement, already scheduled for examination at the 
OMI during the 4 month research window.  In order to collect synovial fluid, verbal consent 
from the decedent’s legal next-of-kin was required.  However, not all families agreed to 
participate in the study.  Thus, a total of 98 samples of synovial fluid were collected in 
combination with traditionally obtained specimens for toxicology screening including: heart 
blood, femoral blood, vitreous humor, and urine.  Of these 98 cases, only 20 cases were 
incorporated into this pilot study as they were available at the time of analysis and had 
documented ethanol present in the blood per toxicology screening samples run at either the 
National Medical Services Lab (NMS) or New Mexico State – Scientific Laboratory Division 
(SLD). 
Synovial fluid from both knees was obtained using a 10ml disposable syringe with a 22-
gauge needle inserted into the subpatellar bursa.  Prior to attempted extraction, the knee joint was 
warmed for 10 minutes with warm water to decrease the viscosity of the synovial fluid, in an 
effort to enhance the volume of the aspirate extracted.  Actual collected volumes varied from 
negligible quantities to 12 ml.  The quality of the sample also varied from yellow-clear to murky 
red-brown.  The sample, combined from both knees, was then transferred to a 10 ml plastic vial 
containing sodium fluoride to prevent/inhibit postmortem organism growth, and tagged with the 
OMI case number.  No other identifiable information (name, date of birth) was included in the 
labeling.  The tubes were kept frozen until the time of analysis by the reference laboratory. 
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Other toxicology screening samples such as heart and femoral blood, urine, and vitreous 
fluid were collected and stored per general autopsy/OMI protocols by employees of the facility 
not involved in this research project.   
 
Analytical Methods 
 Blood samples were processed according to routine OMI protocol at either the National 
Medical Services Laboratory or by the New Mexico State Scientific Laboratory Division 
(depending on lab availability and turn around time).  Protocols for gas chromatograph alcohol 
analysis on blood were similar but not alike between facilities.  In all cases, blood samples were 
preserved in vials containing 2% sodium fluoride until time of analysis.  For analysis purposes, 
blood samples (usually 200 uL) were placed in vials along with 0.08 g/dL of the internal 
standard N-propanol and 0.04 g/dL to t-butanol in NaCl to facilitate the collection of volatiles in 
the headspace area.  An aliquot of the headspace gas (usually 100uL) was then injected into the 
isothermal gas chromatograph for detection, identification, and quantification purposes.  As both 
laboratories calibrate their systems to similar commercial standards as well as the internal 
standard of N-propanol, it was assumed for the purposes of this pilot study that the concentration 
of ethanol present in case samples was equivalent between laboratories.  
Synovial fluid was analyzed at TriCore Reference Laboratories in Albuquerque, New 
Mexico, using their volatile alcohols by gas chromatography protocol, 2008.  This protocol was 
designed for acceptable specimen types of serum, plasma, and urine, but was extended to include 
synovial fluid as part of the present experimental study.  No prior protocol existed at TriCore for 
the analysis of synovial fluid, nor was one detailed in the literature.  The instrument used was the 
Agilent 6850 with the Agilent column DB-ALC2.32x30x1.2, set to a column temperature of 
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40oC, injector temperature of 250oC, detector temperature of 300oC, and operating at a flow rate 
of 80cm/sec.  The gas chromatograph was calibrated against a Cerilliant Multi-component 
alcohol control standard, a negative control, and during the run by a stock internal standard of N-
propanol.   
Samples were prepared for analysis by the addition of hyaluronidase when necessary to 
decrease the viscosity of the synovial fluid.  Subsequently, 100.0uL of the synovial fluid 
specimen was added to an 8ml screw top sample vial containing 100.0uL of an internal standard 
(N-propanol) and approximately 0.3gm of NaCl.  Salt was added to facilitate the concentration of 
the non-polar volatiles in the vial headspace.  A measured aliquot (500uL) of the vapor in the 
head space was subsequently injected into the gas chromatograph for identification and 
quantification purposes. (Figure 1)   
 
 
 
 
 
 
 
Figure 1.  Alcohol Gas Chromatography.  A:  Measured peaks of multi-component alcohol 
standard include methanol (1.077), ethanol (1.378), acetone (1.548), isopropanol (1.642), and 
N-propanol (2.485).  B:  Positive synovial fluid specimen demonstrating ethanol peak and 
internal standard.  Area under the curve corresponds to the quantity of alcohol present.   
 
 
 
B.  Synovial Fluid Sample A.  Multi-component Alcohol Standard 
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Statistical Methods 
 The data was compiled and analyzed using SAS software version 9.1 to determine degree 
of correlation against existing postmortem screening methods for toxicology.  The relationship 
between blood and synovial concentration was evaluated using a Pearson correlation coefficient, 
a quantitative measure of the relationship between two variables.  
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Results 
 The cases utilized in this pilot study are a convenience sample representing those 
decedents who presented at the OMI during the research window and for whom authorization for 
sample collection was obtained.  Males were over represented in the population (80% vs. 20%) 
and tended to be older than females, with median age 49 vs. 35 years, but this difference was not 
statistically significant.  The sample cases demonstrated ethnic diversity including white non-
Hispanic, white Hispanic, and Native Americans.  However, being a convenience sample, white 
Hispanics and Native Americans were under represented in the data set when compared to New 
Mexico demographic statistics (White Hispanic (30% vs. 43%), Native American (5% vs. 10%), 
White non-Hispanic (65% vs. 44%)(BBER, 2007).  See Table 1.   
 
Table 1:  Patient Demographics 
  
Number 
(%) 
Median Age 
(Range) 
Mean BEC 
(Range) 
Mean SEC 
(Range) 
Sex 
Males 16 (80%) 49 (19-65) 98.3 (12-237) 63.0 (0-251) 
Females 4 (20%) 35 (15-42) 138.5 (11-289) 168.4 (85-323) 
      
Race/ethnicity 
White non-
Hispanic 13 (65%) 50 (15-65) 90.1 (11-289) 86.6 (0-323) 
White 
Hispanic 6 (30%) 30 (19-42) 156.8 (25-220) 83.6 (0-250.7) 
Native 
American 1 (5%) 41 14 0 
  
 The subjects’ profiles and causes of death are given in Table 2, along with measured 
values of blood and synovial fluid ethanol content.  The synovial fluid ethanol content values are 
given as the mean values of both knees.  Correlation statistics are provided in Table 3.  Through 
regression analysis, a generally linear relationship with a correlation coefficient of 0.96 was 
obtained between blood ethanol content and synovial fluid ethanol content (Figure 2). 
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Table 2 
Subjects’ profiles, ethanol concentrations, and cause of death 
 
CASE 
No. ETHNICITY 
Ethanol concentration 
(mg/dl) Cause of Death BEC/SEC Ratio  
    Blood Synovial     
1 White 14 23.3 0.60 CO poisoning 
2 White 214 162.97 1.31 Cardiovascular Disease 
3 White 13 0   CO poisoning 
4 Hispanic 208 Clotted   Blunt Trauma 
5 White 74 84.69 0.87 Gun Shot Wound 
6 White 237 231.45 1.02 Asphyxia 
7 White 20 0   Drug intoxication 
8 Hispanic 180 QNS*   Drug intoxication 
9 Hispanic 100 0   Drug intoxication 
10 Native Am 14 0   CO poisoning 
11 White 289 322.78 0.90 Drug intoxication 
12 White 11 QNS*   Drug intoxication 
13 White 49 0   Drug intoxication 
14 White 206 188.06 1.10 Drug intoxication 
15 Hispanic 220 250.71 0.88 Drug intoxication 
16 Hispanic 208 QNS*   Chronic alcoholism 
17 White 17 0   COPD 
18 White 15 27.06 0.55 Drug intoxication 
19 Hispanic 25 0   Drug intoxication 
20 White 12 0   Chronic alcoholism 
*QNS (quantity not sufficient) 
 
 
Table 3 
Pearson Correlation Coefficient 
  Blood Ethanol (mg/dl)   
  0.95651 Pearson Correlation Coefficient 
Synovial Ethanol (mg/dl) <.0001 Prob > |r| under H0: Rho=0 
  16 Number of Observations 
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Comparison of ethanol concentration in the blood 
(BEC) and synovial fluid (SEC)
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Figure 2. Comparison of ethanol concentrations in the blood (BEC) and synovial fluid (SEC).  
Regression equation (y=1.06x – 19.95); x, BEC; y, SEC; r=0.96, n=16. 
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Discussion 
 Of the 20 cases selected for analysis in the present study, 4 samples of synovial fluid 
could not be used due to insufficient quantities or sample quality (Table 2).  The 16 synovial 
fluid samples examined in this pilot study demonstrated a linear relationship between blood and 
synovial fluid ethanol concentration.  The data were strongly positively correlated with a Pearson 
correlation coefficient of 0.96, p<0.0001 and was in agreement with the previously published 
papers of Winek (1993) and Ohshima (1997) as well as with the original studies performed by 
Aurdlicky in Germany which were published in 1965 and 1971.  These original papers were not 
obtainable here, and thus information regarding Aurdlicky’s work is based on the summary done 
by Ohshima.  To date, there are now 5 studies, including this one, that specifically look at the 
correlation between blood and synovial ethanol content.  Despite a continued problem with small 
sample size, these studies all demonstrate not only statistically significant correlation but 
remarkable agreement between studies despite different study designs and sample/data analysis 
(Table 4). 
 
Table 4:  Comparison of sample size, ratio of blood ethanol to synovial ethanol concentration, 
and correlation between four previously published independent studies and this pilot study.   
Source Sample # BEC/SEC ± SD Correlation 
Coefficient 
Aurdlicky, 1965 8 0.72 ± 0.18 0.88 
Aurdlicky, 1971 14 1.03 ± 0.29 0.93 
Winek, 1993 28 0.99 ± 0.29 0.89 
Ohshima, 1997 11 0.76 ± 0.12 0.97 
Present * 8 0.91 ± 0.25 0.96 
*The present study had a sample size of 20 but detected ethanol in the synovial fluid at a concentration of > 0.0 mg/dL in only 8 of the samples.  
Correlation coefficient is based on all 16 samples that were analyzed by GC.  4 of the samples of synovial fluid could not be run for technical 
reasons (table 2). Note: labels were changed from conventions used by Ohshima and Winek (BAC/SAC to BEC/SEC), to specify ethanol as 
opposed to the more general term “alcohol”. 
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 For some reason, the synovial fluid samples in this study seemed to not be particularly 
sensitive to low blood ethanol concentrations.  Eight samples were reported as having no ethanol 
present despite a median BEC of 18.5 mg/dL ± 30.3.  The median BEC in the eight cases that 
were successful in documenting the presence of ethanol in the synovial fluid was 210 mg/dL ± 
107.5.  In Ohshima’s study, the median BEC was 194.5 mg/dL ± 131.3 with the lowest recorded 
BEC being 26 mg/dL.  As the Ohshima study did not extend as far into the low range of ethanol 
concentrations as the present study, it is not possible to say whether or not low synovial fluid 
sensitivity is to be expected when BEC is less than approximately 20 mg/dL.  One possible 
explanation for why ethanol was not detected at these low BEC’s, is that the subject died during 
the absorption phase of ethanol metabolism implying that ethanol consumption first commenced 
very near to the time of death.  As synovial fluid is an ultrafiltrate of the blood plasma, it like 
vitreous fluid, may reflect ethanol levels in the blood 1-2 hours prior to death (DiMaio & 
DiMaio, 2001).  To fully understand this issue, future research will have to focus on 
differentiating between the elimination and absorption phases of ethanol metabolism, as well as 
to elucidate any issues associated with the timing between demise and actual sample collection.   
 The original intent of this study was ambitious.  The aim was to obtain a more robust 
sample size than had been done in prior studies, with the intention to correlate synovial fluid 
toxicology with not only blood ethanol, but also with other drugs of abuse which are routinely 
detected in postmortem blood, vitreous fluid, and urine.  Unfortunately, numerous obstacles 
prevented the realization of the original study proposal. 
 Sample collection proved to be more difficult than originally anticipated.  The need for 
timely autopsy required that consent be obtained less than twenty-four hours after the arrival of 
the decedent’s body at the Office of the Medical Investigator (OMI).  Often, next of kin contact 
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information was unavailable, or families were unreceptive to the idea of participation in a 
research study while acutely grieving.  In addition, synovial fluid extraction proved difficult as 
bodies were refrigerated in the OMI prior to scheduled autopsy, thus making the already viscous 
synovial fluid more so.  Over time the extraction protocol evolved to heating the knee joint with 
warm tap water for 10 minutes to facilitate aspiration and increase the yield.  Despite these 
modifications in protocol and increasing researcher experience in aspiration, the volume of 
aspirate varied dramatically from body to body, with no apparent relationship between body size 
or gender. 
 Laboratory analysis of the samples was delayed far beyond original study timelines.  
Blood, vitreous fluid, and urine were analyzed by NMS or SLD within one to two months of 
autopsy.  Synovial fluid sample analysis was dependent on TriCore, according to a prearranged 
agreement with the toxicology department.  Due to unforeseen circumstances, the chain of 
custody of the synovial samples was disrupted, resulting in the misplacement of 33 samples, 
which were never located.  Possible repeated freezing and thawing of samples may have also 
occurred as the location of the samples moved between the OMI and TriCore, and within 
divisions at TriCore.  As ethanol is a volatile fluid, there was concern that some of the content 
may have been lost due to desiccation, freeze/thaw cycles, synovial fluid matrix disruption 
during pilot testing of the gas chromatograph protocol, and bottle leakage.  However, per 
TriCore documentation (Volatile alcohols by GC, 2008), it is stated that specimens collected in 
fluoride preservative (NaFl-grey top) vials for ethanol testing are stable at 4oC for at least one 
year so the delay to time of analysis may not have been as problematic as originally thought.   In 
any event, the synovial fluid remained unanalyzed for approximately one year from the date of 
their original collection.   
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 The study was originally designed to significantly demonstrate the correlation between 
blood ethanol and synovial fluid ethanol content.  The power analysis run using the lowest 
published correlation coefficient of 0.71 showed that a sample size as low as 16 was adequate to 
provide a power level of 0.9 with a significance of 0.05 or less.  Thus, despite the problems 
enumerated above, the original power analysis supports that the present study has enough data 
for statistical significance.  Further, the results are surprisingly strong, with a Pearson’s 
correlation coefficient of 0.96, and a p<0.0001.   
 Therefore, though unable to extend past research, the present study supports the linear 
relationship between blood and synovial fluid ethanol contents.  Given this linear relationship, 
synovial fluid is a viable postmortem toxicology sample when blood is not available.  
Anecdotally, there was one case during the course of the present study, where the decedent was 
significantly decomposed, and where the traditional samples of blood and vitreous fluid were 
unavailable due to body desiccation, yet a fair quantity of clear-yellow synovial fluid was 
obtained.  The present research also dramatically reveals the stability of synovial fluid ethanol 
content through various adverse conditions over the course of a year’s storage. 
 Though this study was plagued by numerous unforeseen difficulties, synovial fluid 
analysis still has great potential when applied to the field of forensic toxicology.  Given that 
synovial fluid is an isolated ultrafiltrate, free of metabolic enzymes, it, like vitreous fluid, is in a 
unique position to potentially be an alternative way to accurately determine an ethanol level at 
the time of death despite decompositional changes.  Future research to specifically examine the 
time-lag to achieve equilibrium between blood and synovial ethanol content would be useful in 
helping to differentiate between the absorption and elimination phases of blood ethanol.  This in 
turn, would further help to establish the time-interval between ethanol intake and death and thus 
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provide further evidence toward a potential cause of death.  Secondly, synovial fluid analysis has 
the potential to be used for the detection of other drugs of abuse and their metabolites such as 
narcotics, stimulants, hallucinogens, etc.  The current protocols for testing for these drugs often 
require larger samples than could be routinely aspirated from synovial joints.  Thus, a goal of 
future research would be to either develop techniques to more efficiently extract synovial fluid in 
larger quantities, or establish new gas chromatograph protocols, which can utilize smaller sample 
sizes.  Ohshima in the 1997 study, used a Curie-point pyrolyser connected to the GC apparatus 
(known as the Py-GC method) to analyze both blood and synovial samples.  This technique had 
the advantage that it required only a sample of 1 uL vs. the 100 uL used in the present study and 
may be an indication as to how similar samples should be analyzed in the future.  Lastly, when 
adequate blood samples are not available, current toxicology screening protocols will then turn to 
either urine or vitreous fluid.  To further progress the science behind synovial fluid analysis, 
future studies should look to directly compare synovial fluid findings with those found in 
simultaneously collected blood, urine and vitreous fluid samples.   
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